Chips Act Funding Is Aligned With the Will of Congress
The Commerce Department responds on the broadening of the semiconductor subsidy program.
Help Wanted: Retired Bank Examiners to Unravel Bond Mess
Regulators are sending job letters to former employees as they look to beef up bank oversight.
Orcas Now Hate Our Boats, and That’s Just a Start
With killer whales suddenly ruining our fun, are bears, raccoons and ducks next?
June Jobs Report Keeps Fed on Track to Raise Rates in July
The Federal Reserve is on course to raise interest rates to a 22-year high later this month to combat inflation.
This School’s New Security Aide Has 360-degree Vision. It’s a Robot
Santa Fe is one of few school districts experimenting with robot surveillance on their campuses.
Inside the Clandestine Russian Security Force That Took Evan Gershkovich
FSB unit is also believed responsible for strange incidents that blurred the lines between spycraft and harassment, including the mysterious death of […]
China’s Ant Group Slapped With Nearly $1 Billion Fine
Ant Group, the financial-technology company associated with billionaire Jack Ma, was fined by China’s financial regulators, taking the company closer to the […]
Dow Jones Asks U.N. Rights Official to Press Russia for Evan Gershkovich’s Release
The Wall Street Journal reporter has been detained for 100 days.
Investors Bought Nearly $1 Billion in Land Near a California Air Force Base. Officials Want to Know Who Exactly They Are.
Government officials are investigating large land acquisitions near Travis Air Force Base, concerned that foreign interests could be behind the investment group […]
In Miami, the Hamptons and Los Angeles, It’s Private Chef Season
Over the summer, chefs migrate to clients’ vacation homes, cooking up mouthwatering meals and social-media content: “Hamptons summer is like our Olympics.”
The Quirk That Let Wisconsin’s Governor Raise School Funding for 400 Years
The state has an unusual history of striking words and numbers from bills—meet the ”Vanna White Veto.”
Obesity Drugs Won’t Starve These Other Potential Blockbusters
Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last […]